To cleanly dissect the molecular and cellular effects of SF3B1K700E, we developed isogenic MEC1 CLL cell lines carrying or not the most frequent (K700E) SF3B1 mutation using CRISPR/Cas9-genome editing. The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.